DE763362T1 - Pharmazeutisches Grundbestandteil und seine Verwendung - Google Patents
Pharmazeutisches Grundbestandteil und seine VerwendungInfo
- Publication number
- DE763362T1 DE763362T1 DE0763362T DE96401820T DE763362T1 DE 763362 T1 DE763362 T1 DE 763362T1 DE 0763362 T DE0763362 T DE 0763362T DE 96401820 T DE96401820 T DE 96401820T DE 763362 T1 DE763362 T1 DE 763362T1
- Authority
- DE
- Germany
- Prior art keywords
- oil
- pharmaceutical base
- pharmaceutical
- hydrophobic solvent
- beeswax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004615 ingredient Substances 0.000 title 1
- 239000003937 drug carrier Substances 0.000 claims 11
- 230000002209 hydrophobic effect Effects 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 239000002904 solvent Substances 0.000 claims 6
- 235000013871 bee wax Nutrition 0.000 claims 5
- 239000012166 beeswax Substances 0.000 claims 5
- 239000008159 sesame oil Substances 0.000 claims 4
- 235000011803 sesame oil Nutrition 0.000 claims 4
- 239000008158 vegetable oil Substances 0.000 claims 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims 2
- 235000019486 Sunflower oil Nutrition 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000010775 animal oil Substances 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 239000003921 oil Substances 0.000 claims 2
- 235000019198 oils Nutrition 0.000 claims 2
- 238000003756 stirring Methods 0.000 claims 2
- 239000002600 sunflower oil Substances 0.000 claims 2
- 229940076810 beta sitosterol Drugs 0.000 claims 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims 1
- 229960004022 clotrimazole Drugs 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 229960001347 fluocinolone acetonide Drugs 0.000 claims 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 claims 1
- 229950005143 sitosterol Drugs 0.000 claims 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Claims (1)
- Ansprüche1. Pharmazeutische Grundlage, die 5 bis 25 Gew.-% Bienenwachs und 95 bis 75 Gew.-% eines hydrophoben Lösungsmittels enthält und eine durch das Bienenwachs gebildete Netzwerkstruktur aufweist, in der das hydrophobe Lösungsmittel eingeschlossen ist.2. Pharmazeutische Grundlage nach Anspruch 1, bei der das hydrophobe Lösungsmittel ein pflanzliches oder tierisches Öl ist.3. Pharmazeutische Grundlage nach Anspruch 2, bei der das pflanzliche Öl Sesamöl, Rapsöl oder Sonnenblumenöl ist.4. Pharmazeutische Grundlage nach Anspruch 3, bei der das Öl Sesamöl ist.5. Verfahren zur Herstellung einer pharmazeutischen Grundlage, das folgende Schritte umfaßt:(1) Erhitzen eines hydrophoben Lösungsmittels und Rühren;(2) Erhitzen von Bienenwachs auf eine Temperatur, die gerade oberhalb seines Schmelzpunkts liegt, um es zu verflüssigen,und(3) Zugabe des verflüssigten Bienenwachses zu dem hydrophoben Lösungsmittel bei einer Temperatur von 60 bis 180 0C, auf die es in Schritt (1) erhitzt wurde, in einer solchen Menge, daß das Bienenwachs 5 bis 25 Gew.-% der Gesamtmenge der pharmazeutischen Grundlage ausmacht, kräftiges Rühren und anschließendes spontanes Abkühlen unter Erhalt der pharmazeutischen Grundlage.96-51.267 DeEP-SF-BkS. Verfahren nach Anspruch 5, wobei das hydrophobe Lösungsmittel ein pflanzliches Öl oder ein tierisches Öl ist.7. Verfahren nach Anspruch 6, wobei das pflanzliche Öl Sesamöl, Rapsöl oder Sonnenblumenöl ist.8. Verfahren nach Anspruch 7, wobei das Öl Sesamöl ist.9. Verfahren nach Anspruch 7, wobei in Schritt (1) eine akzeptable und wirksame Menge eines pharmazeutischen Wirkstoffs der pharmazeutischen Grundlage zugesetzt werden kann.10. Verfahren nach Anspruch 9, wobei der pharmazeutische Wirkstoff unter ß-Sitosterin, Sulfadiazin-Silber, Clotrimazol und Fluocinolonacetonid ausgewählt werden kann.11. Pharmazeutisches Mittel zur äußeren Anwendung, das die pharmazeutische Grundlage nach Anspruch 1 enthält.12. Material, das die pharmazeutische Grundlage nach Anspruch 1 enthält.13. Kosmetisches Produkt, das die pharmazeutische Grundlage nach Anspruch 1 zur äußeren Anwendung enthält.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95116651A CN1062129C (zh) | 1995-09-14 | 1995-09-14 | 药物基质及其用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE763362T1 true DE763362T1 (de) | 1997-07-10 |
Family
ID=5080983
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE0763362T Pending DE763362T1 (de) | 1995-09-14 | 1996-08-26 | Pharmazeutisches Grundbestandteil und seine Verwendung |
DE69629988T Expired - Lifetime DE69629988T2 (de) | 1995-09-14 | 1996-08-26 | "Pharmazeutische Grundlage in Salbenform und ihre Verwendung" |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69629988T Expired - Lifetime DE69629988T2 (de) | 1995-09-14 | 1996-08-26 | "Pharmazeutische Grundlage in Salbenform und ihre Verwendung" |
Country Status (5)
Country | Link |
---|---|
US (1) | US5817322A (de) |
EP (1) | EP0763362B1 (de) |
JP (1) | JP3065530B2 (de) |
CN (1) | CN1062129C (de) |
DE (2) | DE763362T1 (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL126741A0 (en) * | 1998-10-25 | 1999-08-17 | Yam Daniel | Solidification of fluid oils and their use |
US6967023B1 (en) | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
US8512718B2 (en) * | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US6685971B2 (en) * | 2001-06-28 | 2004-02-03 | Rongxiang Xu | Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
CN1827766B (zh) * | 2001-06-28 | 2010-08-25 | 徐荣祥 | 体外细胞的培养方法 |
US6972195B2 (en) * | 2002-09-27 | 2005-12-06 | Rongxiang Xu | Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
CA2502986C (en) | 2002-10-25 | 2011-08-23 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7700076B2 (en) * | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US7320451B2 (en) * | 2003-06-06 | 2008-01-22 | Funai Electric Co., Ltd. | Stand for liquid crystal television and stand for liquid crystal display |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
TWI374755B (en) * | 2004-12-17 | 2012-10-21 | Kao Corp | Makeup composition |
GB0502337D0 (en) * | 2005-02-04 | 2005-03-16 | Univ York | Isolation and fractionation of waxes from plants |
AU2006298442A1 (en) | 2005-05-09 | 2007-04-12 | Foamix Ltd. | Saccharide foamable compositions |
KR101160695B1 (ko) * | 2005-10-19 | 2012-06-28 | 삼성전자주식회사 | 거치대의 지지 수단 |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
JP4548621B2 (ja) | 2008-05-15 | 2010-09-22 | 岩崎通信機株式会社 | スタンド付き電子機器 |
FR2943891B1 (fr) * | 2009-04-03 | 2011-10-07 | Sas Genialis | Huile vegetale et produits derives pour l'industrie alimentaire. |
WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
CN101991688A (zh) * | 2009-08-20 | 2011-03-30 | 徐荣祥 | 药物组合物在制备治疗糖尿病溃疡药物中的用途 |
WO2011039637A2 (en) | 2009-10-02 | 2011-04-07 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US10046079B2 (en) | 2013-03-15 | 2018-08-14 | Materials Modification Inc. | Clay composites and their applications |
US10258631B2 (en) | 2014-08-28 | 2019-04-16 | Board Of Regents, The University Of Texas System | Formulations of testosterone and methods of treatment therewith |
BR112018067554A2 (pt) * | 2016-03-02 | 2019-03-06 | Medcara Pharmaceuticals, Llc | formulações de testosterona e métodos de tratamento com as mesmas |
JP6131362B1 (ja) * | 2016-03-29 | 2017-05-17 | 剤盛堂薬品株式会社 | 漢方軟膏剤の製造方法 |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
CN107899015A (zh) * | 2017-11-14 | 2018-04-13 | 李俐 | 药物组合物在调节成纤维细胞生长中的用途 |
CN108853050A (zh) * | 2018-08-29 | 2018-11-23 | 北京荣祥再生医学研究所有限公司 | 一种药物载体在制备抗糖尿病药物组合物中的应用 |
CN110237038B (zh) * | 2019-06-13 | 2021-09-21 | 华中农业大学 | 一种nadh载药微球 |
CN110887720A (zh) * | 2019-12-11 | 2020-03-17 | 武汉原谷生物科技有限责任公司 | 一种免疫组化笔半固体笔泥及其制备方法 |
US20230248781A1 (en) * | 2020-07-08 | 2023-08-10 | Beijing Rongxiang Institute Of Regenerative Medicine Co., Ltd. | Method for regulating expression level of musashi1 in cells |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB422940A (en) * | 1932-12-10 | 1935-01-22 | Kerasin Ltd | Process of producing cosmetic salves or basic substances for salves |
US3761590A (en) * | 1970-05-18 | 1973-09-25 | Research Corp | Silver sulfadiazine used in the treatment of burns |
GB1503388A (en) * | 1975-07-01 | 1978-03-08 | Inverni Della Beffa Spa | Pharmaceutically active complexes and pharmaceutical compositions containing them |
US4279901A (en) * | 1979-12-31 | 1981-07-21 | American Cyanamid Company | Topical ointment |
DE3246265C2 (de) * | 1982-12-14 | 1984-09-20 | Veronica 8000 München Rudder | Dermatotherapeutikum zur Anregung und Förderung des Haarwuchses |
ES8800125A1 (es) * | 1985-03-13 | 1987-11-01 | Kao Corp | Un procedimiento para la preparacion de trigliceridos de acidos mixtos. |
US4623667A (en) * | 1985-06-28 | 1986-11-18 | Richardson-Vicks Inc. | Topical treatment of skin inflammatory disorders |
IL79765A (en) * | 1985-08-23 | 1992-02-16 | Lilly Co Eli | Injectable sustained release formulations of bovine somatotropin |
US4820523A (en) * | 1986-04-15 | 1989-04-11 | Warner-Lambert Company | Pharmaceutical composition |
US5002938A (en) * | 1988-03-21 | 1991-03-26 | Bristol-Myers Squibb Company | Antifungal gel formulations |
JPH0253709A (ja) * | 1988-08-18 | 1990-02-22 | Tosoh Corp | 揺変性半固体組成物 |
CN1052789A (zh) * | 1989-07-31 | 1991-07-10 | 周学林 | 一种烧伤药膏的制备方法 |
ES2023544A6 (es) * | 1990-04-06 | 1992-01-16 | Tong Il S L | Procedimiento de fabricacion de un producto alimenticio a base de aceite de germen de trigo |
CN1068500A (zh) * | 1992-06-16 | 1993-02-03 | 沈阳东方制药厂 | 一种治疗妇科疾病的栓剂工艺方法 |
CN1045059C (zh) * | 1993-01-15 | 1999-09-15 | 徐荣祥 | 一种治疗温血动物或人类热损伤的药用组合物及其制法 |
US5449551A (en) * | 1993-06-03 | 1995-09-12 | Kawano Paper Co., Ltd. | Highly water absorbent fibrous web and a process for producing the same |
US5597849A (en) * | 1994-11-14 | 1997-01-28 | Medical Polymer Technologies, Inc. | Stick formulations for topical drug delivery of therapeutic agents and uses thereof |
-
1995
- 1995-09-14 CN CN95116651A patent/CN1062129C/zh not_active Expired - Lifetime
-
1996
- 1996-03-22 US US08/620,163 patent/US5817322A/en not_active Expired - Lifetime
- 1996-04-22 JP JP8099723A patent/JP3065530B2/ja not_active Expired - Lifetime
- 1996-08-26 EP EP96401820A patent/EP0763362B1/de not_active Expired - Lifetime
- 1996-08-26 DE DE0763362T patent/DE763362T1/de active Pending
- 1996-08-26 DE DE69629988T patent/DE69629988T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0763362B1 (de) | 2003-09-17 |
JPH0977687A (ja) | 1997-03-25 |
JP3065530B2 (ja) | 2000-07-17 |
US5817322A (en) | 1998-10-06 |
EP0763362A3 (de) | 1998-04-08 |
CN1062129C (zh) | 2001-02-21 |
DE69629988D1 (de) | 2003-10-23 |
DE69629988T2 (de) | 2004-07-15 |
EP0763362A2 (de) | 1997-03-19 |
CN1145779A (zh) | 1997-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE763362T1 (de) | Pharmazeutisches Grundbestandteil und seine Verwendung | |
DE69521512T2 (de) | Neues pharmazeutisches präparat zur schmerzbehandlung | |
DE69311352T2 (de) | Zusammensetzung zur oberflächenbehandlung | |
DE3131610A1 (de) | "auflage mit einem gehalt an mikroverkapseltem nitroglyzerin, die zur perkutanten verabreichung von nitroglyzerin geeignet ist" | |
DE69213930T2 (de) | Fettzubereitungen und ihre verwendung in emulsionsprodukten wie kosmetika and pharmazeutika | |
DE3246265C2 (de) | Dermatotherapeutikum zur Anregung und Förderung des Haarwuchses | |
DE3873889T2 (de) | Mischung, bestehend aus 1,8-hydroxy-und/oder acyloxyanthracen oder anthron- und pyrimidinderivaten zum induzieren und stimulieren des haarwuchses und zum vermindern des haarausfalls. | |
DE1492118C3 (de) | Körperpflegemittel | |
DE19708478A1 (de) | Honig- Kräuter- Badezusatz | |
DE4401554A1 (de) | Präparat zur Therapie und Prophylaxe von Erkrankungen, die bei Imbalancen von Plasmalipiden auftreten | |
EP0097813A1 (de) | Insektenvertreibungsmittel | |
DE1692538B2 (de) | Margarineöl | |
DE2612038C2 (de) | ||
EP0090288B1 (de) | Insektenvertreibungsmittel | |
DE19634206C2 (de) | Hautpflegemittel, insbesondere für alternde Haut | |
DE2144249A1 (de) | Kosmetika | |
DE1067180B (de) | hautpflegemittel | |
DE2654743C2 (de) | Verwendung eines Gemisches als Therapeutikum zur externen Behandlung von Schuppenflechte (Psoriasis), Flechten und Ekzemen | |
EP0097812A1 (de) | Insektenvertreibungsmittel | |
AT396746B (de) | Verfahren zur herstellung einer hautcreme | |
DE2154526C3 (de) | Haarbehandlungsmittel und Verfahren zu dessen Herstellung | |
EP0230226B1 (de) | Antimykotische Emulsionen | |
EP0090287B1 (de) | Insektenvertreibungsmittel | |
RU2093138C1 (ru) | Крем для кожи лица "ясная поляна" | |
EP0176929A3 (de) | Diazepine enthaltende pharmazeutische Zusammensetzungen mit Plättchen aktivierender Faktor (PAF)-antagonistischer Wirkung |